date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Contacts
Similar Companies999
ElsaLys Biotech
ElsaLys Biotech is a French company that develops therapeutic monoclonal antibodies.
Sector
Subsector
Location
total rounds
total raised
Raven Biotechnologies
Raven Biotechnologies develops monoclonal antibody therapeutics for cancer treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
APITBIO
The company is a biotechnology firm that develops anti-cancer drugs based on antibodies.
Sector
Subsector
Keywords
Location
total rounds
total raised
Nascent Biotech
Nascent Biotech develops innovative therapeutic antibodies to treat cancer.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Genentech
announced date
price
Financials
Co-Investors
People
Founders2
Tse Wen Chang
Over 40 years of experience spanning academia and industry. He founded Tanoxand served as VP of R&D and as a board member, focusing on developing new drugsbased on antibody structure. He also discovered anti-IgE therapeutics, leading to thedevelopment of Xolair, a drug indicated for many IgE-mediated diseases. He acquiredThe World Academy of Sciences (TWAS) Prize in Medical Sciences and was selectedas Honorary Fellow by the American College of Allergy, Asthma, and Immunology(ACAAI) twice. PhD, Harvard University. Postdoctoral Fellow, MIT.
current job
organization founded
Tse Wen Chang
Nancy T. Chang
Nancy T. Chang, Ph.D. has served as a Director at Ansun since 2011. Since 2007, Dr. Chang has served as the President of Apex Enterprises, Inc., an investment management company with a major focus on healthcare investments. From 2007 to 2012, she was the Chairperson and Senior Managing Director of Caduceus Asia Partners at OrbiMed Advisors L.L.C. From 1987 to 2007, Dr. Chang served as Co-Founder, President and Chairman of Tanox, Inc., which was sold to Genentech in 2007. Prior to founding Tanox, Dr. Chang held several leadership positions at Centocor, now a division of Johnson & Johnson. She was also an Associate Professor at Baylor College of Medicine, and before that, she worked at the Roche Institute of Molecular Biology. She has served on the boards of a number of companies, including Charles River Laboratories International, Inc., Applied Optoelectronics Inc. and is currently a member of the board of directors of SciClone Pharmaceuticals, Inc. In addition, Dr. Chang was a member of the board of directors at the Biotechnology Industry Organization (BIO) and BioHouston. Dr. Chang also was a Director at the Federal Reserve Bank in the Dallas Houston Branch, and was a Director for Project Hope. She has published more than 35 papers on topics ranging from monoclonal antibodies to HIV and holds seven patents. Dr. Chang received her Doctorate in Biological Chemistry from Harvard University.
current job
count Of Investments
Nancy T. Chang
Employee Profiles4
William Jenkins
Strategic Consultant To the Pharmaceutical Industry